approval
saveBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval
February 12, 2024updated 5mo ago
community read0 votes
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 5
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalFeb 12, 2024
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalFeb 12, 2024
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalFeb 12, 2024
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE: BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 15, 2023
- approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 15, 2023
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE33 co-mentions · 11 sources
- tagSmall Molecule29 co-mentions · 29 sources
- drugStem Cell Therapy for Coronavirus Disease 2019 (COVID-19)22 co-mentions · 11 sources
- drugaspirin22 co-mentions · 11 sources
- drugSYNALGOS-DC22 co-mentions · 11 sources
- drugcodeine11 co-mentions · 11 sources
- drugcaffeine11 co-mentions · 11 sources
comments(0)
5-min edit window · permanent after that